Previous Market Closed Nifty Closed at 14507.30 up by 182.4 points Sensex Closed at 49,008.50 down by 568.38 points Last year, zero-coupon bonds or deep discount bonds was a favourite instrument of the Indian government to recapitalize the banks, as it did not create immediate liability. However, after the concerns expressed by the RBI, the government may choose to
News Announcement Impact Analysis ·GST Collections for December 2020 touches all-time high of Rs.1.15 trillion ·This is the highest monthly collection ever and is in sync with the rapid recovery in output of goods and services ·This represents a 12% growth on a YOY basis and a growth of 9.7% on a sequential basis ·Core
Air Asia of Malaysia plans to sell 32.67% stake in Indian operations to Tata Sons for a consideration of $37.7 million. Tatas already own 49% in Air Asia India so this will take their stake closer to 82%. It will gel with the Tatas bid for Air India as it gives them a much bigger
The Rs.16,000 crore buyback program of TCS will commence on December 18, 2020 and close on January 01, 2021. Shareholders have already approved the buyback of 5.33 crore shares at a maximum price of Rs.3,000 per share. As stipulated by SEBI for such buybacks, the letter of offer will be sent to eligible shareholders by
Larsen & Toubro has emerged as the lowest bidder for the C6 unit of the Mumbai-Ahmadabad bullet train project. L&T had quoted Rs.7,289 crore for this phase. This comes on top of L&T already having won the contract to execute C4 package for which L&T had quoted Rs.24,985 crore. The contract to L&T would include
Aditya Puri handed over charge to Sasidhar Jagdishan on 26 October, bringing an end to an illustrious 26-year career. Puri has been with HDFC bank since its day of inception and built it to become one of the most formidable banks in India and also the most valuable bank in terms of market capitalization.
Serum Institute will get an additional $150 million in funding from Bill & Melinda Gates Foundation This is to manufacture an additional 100 million COVID-19 vaccine doses for India and other lower income countries. Now the enhanced manufacturing capacity of vaccines stands at 200 million doses. The dosage has been priced at an economical